Establishing statewide standards governing the use of HIV post-exposure prophylaxis, permitting a pharmacist to initiate such medication to certain patients, providing civil liability protections to pharmacists who initiate prophylactic therapy to patients for post-exposure to human immunodeficiency virus.

Latest action: Died in Committee

Voted 4/10/2026View source

Roll-call record

How representatives voted

0 yea·0 nay

No roll-call votes recorded for this bill yet.

Docket history

4/9/2026Withdrawn from Committee on Health and Human Services; Rereferred to Committee on Insurance
3/17/2026Withdrawn from Committee on Insurance; Rereferred to Committee on Health and Human Services
3/13/2026Withdrawn from Committee on Health and Human Services; Referred to Committee on Insurance
3/5/2026Withdrawn from Committee on Insurance; Rereferred to Committee on Health and Human Services
3/4/2026Withdrawn from Committee on Health and Human Services; Referred to Committee on Insurance
1/28/2025Referred to Committee on Health and Human Services
1/27/2025Introduced